Pharmaceuticals, Biotechnology and Life Sciences
The expert ‘Peer Exchange’ panel will discuss the evolving landscape of Alzheimer’s treatment CRANBURY, N.J.–(BUSINESS WIRE)–NeurologyLive®, a multimedia platform dedicated…
Cancer Insight is Instrumental in Securing CPRIT Funding for Companies Developing Novel Cancer Treatments SAN ANTONIO–(BUSINESS WIRE)–#CPRIT–In just under eight…
HUDSON, Wis.–(BUSINESS WIRE)–Phillips-Medisize, a Molex company, announces a significant exhibiting and speaking presence at the Suzhou Dialogue conference, organized by…
DUBLIN–(BUSINESS WIRE)–The “Method Development and Validation for Assays Supporting Testing of Biologics” conference has been added to ResearchAndMarkets.com’s offering. This…
First and only Adenosine A2A receptor antagonist for use in Parkinson’s Disease in the U.S. TOKYO–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd.,…
DUBLIN–(BUSINESS WIRE)–The “Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)” conference has been added to ResearchAndMarkets.com’s offering. This seminar…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and…
DUBLIN–(BUSINESS WIRE)–The “Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment – Issues and Solutions” conference has been added to…
Study designed to evaluate safety, efficacy of the company’s next-generation SurVeil™ drug-coated balloon Company Raises 2019 Revenue and EPS Guidance…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…